Log in to save to my catalogue

HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a951c8fcb43d4002b7844f3a23348587

HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

About this item

Full title

HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2021-11, Vol.12 (12), p.1109-1109, Article 1109

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Chimeric antigen receptor (CAR) - T cell therapy is a new class of cellular immunotherapies, which has made great achievements in the treatment of malignant tumors. Despite improvements in colorectal cancer (CRC) therapy, treatment of many patients fails because of metastasis and recurrence. The human epidermal growth factor receptor 2 (HER2) is a...

Alternative Titles

Full title

HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a951c8fcb43d4002b7844f3a23348587

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a951c8fcb43d4002b7844f3a23348587

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-021-04100-0

How to access this item